NYSE: MDTMedtronic plc Stock
$131.65+1.07 (+0.82%)
Updated Sep 15, 2021
MDT Price
$131.65
Fair Value Price
N/A
Market Cap
$177.18B
52 Week Low
$98.94
52 Week High
$135.89
P/E
45.71x
P/B
3.44x
P/S
5.59x
PEG
1.35x
Dividend Yield
1.8%
Revenue
$31.60B
Earnings
$3.88B
Gross Margin
66.5%
Operating Margin
15.86%
Profit Margin
12.3%
Debt to Equity
0.78
Operating Cash Flow
$7B
Beta
0.89
Next Earnings
N/A
Ex-Dividend
Sep 23, 2021
Next Dividend
Oct 15, 2021
Zen Score
High
Medium
Low
50
Industry average
Reasons for this score
MDT ($131.65) is trading below its intrinsic value of $349.26, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
MDT is good value based on its earnings relative to its share price (45.71x), compared to the US market average -8.74x)
Valuation
MDT is good value based on its earnings relative to its share price (45.71x), compared to the US Medical Devices industry average (51.49x)
Valuation
MDT News
Valuation
MDT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
45.71x
Industry
51.49x
Market
-8.74x
MDT is good value based on its earnings relative to its share price (45.71x), compared to the US market average -8.74x)
Valuation
MDT is good value based on its earnings relative to its share price (45.71x), compared to the US Medical Devices industry average (51.49x)
Valuation
MDT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.44x
Industry
5.39x
MDT is good value based on its book value relative to its share price (3.44x), compared to the US Medical Devices industry average (5.39x)
Valuation
MDT price to earnings growth (PEG)
For valuing profitable companies with growth potential
MDT is poor value relative to its rate of earnings growth, measured by PEG ratio (1.35x)
Valuation
MDT's financial health
Profit margin
Revenue
$8.0B
Net Income
$763.0M
Profit Margin
9.6%
MDT's Earnings (EBIT) of $5.01B can safely cover interest payments on company debt ($25.96B)
Financials
MDT's profit margin has decreased (-3.5%) in the last year from (15.8%) to (12.3%)
Financials
Assets to liabilities
Assets
$91.8B
Liabilities
$40.1B
Debt to equity
0.5
MDT's short-term assets ($22.43B) exceed its short-term liabilities ($7.76B)
Financials
MDT's long-term liabilities ($32.37B) exceed its short-term assets ($22.43B)
Financials
MDT's debt relative to shareholder equity (0.78) has decreased or remained constant compared to 5 years ago (0.94)
Financials
MDT's debt to equity ratio (0.78) is considered high
Financials
Cash flow
Operating
$1.3B
Investing
-$784.0M
Financing
-$1.1B
MDT's operating cash flow ($7.25B) is sufficient to service the company's debt ($25.96B)
Financials
Medtronic Stock FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.